Skip to main content

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

NDRA holding history

ENDRA Life Sciences Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NDRA overviewAll 13F holders of NDRAFull Q2 2026 holdings

Shares (Q2 2026)
3,546
Value
$18.9K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of NDRA by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,546$18.9K<0.1%00.0%UnchangedHolders
Q1 20263,546$16.5K<0.1%−3,400−48.9%ReducedHolders
Q4 20256,946$31.5K<0.1%+6,946NewHolders
Q1 20250$00.0%−13−100.0%Sold outHolders
Q4 202413$81<0.1%−2,602−99.5%ReducedHolders
Q3 20242,615$526<0.1%−7,717−74.7%ReducedHolders
Q2 202410,332$1.00K<0.1%+10,000+3,012.0%AddedHolders
Q1 2024332$193<0.1%00.0%UnchangedHolders
Q4 2023332$704<0.1%−449−57.5%ReducedHolders
Q3 2023781$867<0.1%00.0%UnchangedHolders
Q2 2023781$1.09K<0.1%−24,959−97.0%ReducedHolders
Q1 202325,740$58.9K<0.1%−17,488−40.5%ReducedHolders
Q4 202243,228$175.9K<0.1%00.0%UnchangedConverted for a 1-for-20 splitHolders
Q3 2022864,573$265.0K<0.1%+14,000+1.6%AddedHolders
Q2 2022850,573$199.0K<0.1%00.0%UnchangedHolders
Q1 2022850,573$332.0K<0.1%+6,999+0.8%AddedHolders
Q4 2021843,574$583.0K<0.1%+611,262+263.1%AddedHolders
Q3 2021232,312$402.0K<0.1%00.0%UnchangedHolders
Q2 2021232,312$506.0K<0.1%+11,678+5.3%AddedHolders
Q1 2021220,634$573.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.